Testosterone, frailty and physical function in older men

References

• Beard J, Araujo De Carvalho I. Multisectoral action for a life course approach to healthy ageing: policy paper EB 134/19. ((Ed.^(Eds)). Geneva: World Health Organization; 2016.
   Google Scholar
• Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27(1):1–15.
   PubMed Web of Science ®Google Scholar
• Collard RM, Boter H, Schoevers RA, et al. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60(8):1487–1492.
   PubMed Web of Science ®Google Scholar
• Buta BJ, Walston JD, Godino JG, et al. Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments. Ageing Res Rev. 2016;26:53–61.
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–156.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. Cmaj. 2005;173(5):489–495.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci. 2007;62(7):738–743.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Howlett SE, MacKnight C, et al. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci. 2004;59(12):1310–1317.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589–598.
   PubMed Web of Science ®Google Scholar
• Liu PY, Beilin J, Meier C, et al. Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. J Clin Endocrinol Metab. 2007;92(9):3599–3603.
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Baltimore longitudinal study of A. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2001;86(2):724–731.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European male aging study. J Clin Endocrinol Metab. 2008;93(7):2737–2745.
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Hirani V, et al. Temporal trend in androgen status and androgen sensitive outcomes in older men. J Clin Endocrinol Metab. 2016;101(4):1836-1846.
   Web of Science ®Google Scholar
• Yeap BB, Alfonso H, Chubb SA, et al. Reference ranges and determinants of testosterone, dihydrotestosterone, and estradiol levels measured using liquid chromatography-tandem mass spectrometry in a population-based cohort of older men. J Clin Endocrinol Metab. 2012;97(11):4030–4039.
   PubMed Web of Science ®Google Scholar
• Sartorius G, Spasevska S, Idan A, et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf). 2012;77(7):755–763.
   PubMedGoogle Scholar
• Shi Z, Araujo AB, Martin S, et al. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab. 2013;98(8):3289–3297.
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, Kupelian V, et al. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab. 2007;92(2):549–555.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–135.
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611–624.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ. Testosterone and male aging: faltering hope for rejuvenation. Jama. 2017;317(7):699–701.
   PubMed Web of Science ®Google Scholar
• Goldman AL, Bhasin S, Wu FCW, et al. Reappraisal of testosterone’s binding in circulation: physiological and clinical implications. Endocr Rev. 2017;38:302–324.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ. Free testosterone: pumping up the tires or ending the free ride? Endocr Rev. 2017;38(4):297–301.
   PubMed Web of Science ®Google Scholar
• Petra PH, Stanczyk FZ, Namkung PC, et al. Direct effect of sex steroid-binding protein (SBP) of plasma on the metabolic clearance rate of testosterone in the rhesus macaque. J Steroid Biochem. 1985;22(6):739–746.
   PubMedGoogle Scholar
• Laurent MR, Hammond GL, Blokland M, et al. Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis. Scientific Reports. 2016;6:35539.
   PubMed Web of Science ®Google Scholar
• Matsumoto AM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci. 2002;57(2):M76–99.
   PubMed Web of Science ®Google Scholar
• Yeap BB. Are declining testosterone levels a major risk factor for ill-health in aging men? Int J Impot Res. 2009;21(1):24–36.
   PubMed Web of Science ®Google Scholar
• Schaap LA, Pluijm SM, Smit JH, et al. The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women. Clin Endocrinol (Oxf). 2005;63(2):152–160.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Jasjua GK, Pencina M, et al. Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study. Diabetes Care. 2011;34(11):2464–2470.
   PubMed Web of Science ®Google Scholar
• O’Connor DB, Lee DM, Corona G, et al. The relationships between sex hormones and sexual function in middle-aged and older European men. J Clin Endocrinol Metab. 2011;96(10):E1577–1587.
   PubMed Web of Science ®Google Scholar
• Travison TG, Nguyen AH, Naganathan V, et al. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. J Clin Endocrinol Metab. 2011;96(8):2464–2474.
   PubMed Web of Science ®Google Scholar
• O’Donnell AB, Travison TG, Harris SS, et al. Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2006;91(2):425–431.
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Wang PY, Lee CG, et al. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab. 2011;96(12):3855–3863.
   PubMed Web of Science ®Google Scholar
• Yeap BB, Almeida OP, Hyde Z, et al. Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The health in men study. Clin Endocrinol (Oxf). 2008;68(3):404–412.
   PubMed Web of Science ®Google Scholar
• Mohr BA, Bhasin S, Kupelian V, et al. Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc. 2007;55(4):548–555.
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Ensrud KE, Laughlin GA, et al. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab. 2009;94(10):3806–3815.
   PubMed Web of Science ®Google Scholar
• Hyde Z, Flicker L, Almeida OP, et al. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab. 2010;95(7):3165–3172.
   PubMed Web of Science ®Google Scholar
• Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16(7):601–608.
   PubMed Web of Science ®Google Scholar
• Wu IC, Lin XZ, Liu PF, et al. Low serum testosterone and frailty in older men and women. Maturitas. 2010;67(4):348–352.
   PubMed Web of Science ®Google Scholar
• Carcaillon L, Blanco C, Alonso-Bouzon C, et al. Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging. PLoS One. 2012;7(3):e32401.
   PubMed Web of Science ®Google Scholar
• Eichholzer M, Barbir A, Basaria S, et al. Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male. 2012;15(4):208–215.
   PubMed Web of Science ®Google Scholar
• Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004;7(3):271–277.
   PubMed Web of Science ®Google Scholar
• Taieb J, Mathian B, Millot F, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clin Chem. 2003;49(8):1381–1395.
   PubMed Web of Science ®Google Scholar
• Sikaris K, McLachlan RI, Kazlauskas R, et al. Reproductive hormone reference intervals for healthy fertile young men: evaluation of automated platform assays. J Clin Endocrinol Metab. 2005;90(11):5928–5936.
   PubMed Web of Science ®Google Scholar
• Wang C, Catlin DH, Demers LM, et al. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab. 2004;89(2):534–543.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ, Newman JD, Jimenez M, et al. Performance of direct estradiol immunoassays with human male serum samples. Clin Chem. 2014;60(3):510–517.
   PubMed Web of Science ®Google Scholar
• Harwood DT, Handelsman DJ. Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta. 2009;409(1–2):78–84.
   PubMed Web of Science ®Google Scholar
• Rosner W, Hankinson SE, Sluss PM, et al. Challenges to the measurement of estradiol: an endocrine society position statement. J Clin Endocrinol Metab. 2013;98(4):1376–1387.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ, Wartofsky L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab. 2013;98(10):3971–3973.
   PubMed Web of Science ®Google Scholar
• Shackleton C. Clinical steroid mass spectrometry: a 45-year history culminating in HPLC-MS/MS becoming an essential tool for patient diagnosis. J Steroid Biochem Mol Biol. 2010;121(3–5):481–490.
   PubMed Web of Science ®Google Scholar
• Ly LP, Handelsman DJ. Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol. 2005;152(3):471–478.
   PubMed Web of Science ®Google Scholar
• Ly LP, Sartorius G, Hull L, et al. Accuracy of calculated free testosterone formulae in men. Clin Endocrinol (Oxf). 2010;73(3):382–388.
   PubMed Web of Science ®Google Scholar
• Sartorius G, Ly LP, Sikaris K, et al. Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann Clin Biochem. 2009;46(Pt 2):137–143.
   PubMedGoogle Scholar
• Hackbarth JS, Hoyne JB, Grebe SK, et al. Accuracy of calculated free testosterone differs between equations and depends on gender and SHBG concentration. Steroids. 2011;76(1–2):48–55.
   PubMed Web of Science ®Google Scholar
• Salameh WA, Redor-Goldman MM, Clarke NJ, et al. Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges. Steroids. 2010;75(2):169–175.
   PubMed Web of Science ®Google Scholar
• Zakharov MN, Bhasin S, Travison TG, et al. A multi-step, dynamic allosteric model of testosterone’s binding to sex hormone binding globulin. Mol Cell Endocrinol. 2015;399:190–200.
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Blyth FM, et al. Evaluating calculated free testosterone as a predictor of morbidity and mortality independent of testosterone for cross-sectional and 5 year longitudinal health outcomes in older men: the concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci. 2018;73(6):729-736.
   Web of Science ®Google Scholar
• O’Connell MD, Wu FC. Androgen effects on skeletal muscle: implications for the development and management of frailty. Asian J Androl. 2014;16(2):203–212.
   PubMed Web of Science ®Google Scholar
• Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull. 2010;95:139–159.
   PubMed Web of Science ®Google Scholar
• Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2010;95(2):639–650.
   PubMed Web of Science ®Google Scholar
• O’Connell MD, Roberts SA, Srinivas-Shankar U, et al. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men? J Clin Endocrinol Metab. 2011;96(2):454–458.
   PubMed Web of Science ®Google Scholar
• Atkinson RA, Srinivas-Shankar U, Roberts SA, et al. Effects of testosterone on skeletal muscle architecture in intermediate-frail and frail elderly men. J Gerontol A Biol Sci Med Sci. 2010;65(11):1215–1219.
   PubMed Web of Science ®Google Scholar
• Kenny AM, Kleppinger A, Annis K, et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty. J Am Geriatr Soc. 2010;58(6):1134–1143.
   PubMed Web of Science ®Google Scholar
• Storer TW, Basaria S, Traustadottir T, et al. Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men. J Clin Endocrinol Metab. 2017;102(2):583–593.
   PubMed Web of Science ®Google Scholar
• Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. Jama. 2002;288(18):2282–2292.
   PubMed Web of Science ®Google Scholar
• Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. Jama. 2008;299(1):39–52.
   PubMed Web of Science ®Google Scholar
• Nair KS, Rizza RA, O’Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med. 2006;355(16):1647–1659.
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999;84(8):2647–2653.
   PubMed Web of Science ®Google Scholar
• Travison TG, Basaria S, Storer TW, et al. Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci. 2011;66(10):1090–1099.
   PubMed Web of Science ®Google Scholar
• Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109–122.
   PubMed Web of Science ®Google Scholar
• Storer TW, Woodhouse L, Magliano L, et al. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. J Am Geriatr Soc. 2008;56(11):1991–1999.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Woodhouse L, Casaburi R, et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005;90(2):678–688.
   PubMed Web of Science ®Google Scholar
• Storer TW, Magliano L, Woodhouse L, et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003;88(4):1478–1485.
   PubMed Web of Science ®Google Scholar
• Page ST, Amory JK, Bowman FD, et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab. 2005;90(3):1502–1510.
   PubMed Web of Science ®Google Scholar
• Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61(10):1059–1064.
   PubMed Web of Science ®Google Scholar
• Narici MV, Maffulli N, Maganaris CN. Ageing of human muscles and tendons. Disabil Rehabil. 2008;30(20–22):1548–1554.
   PubMed Web of Science ®Google Scholar
• Reeves ND, Narici MV, Maganaris CN. Myotendinous plasticity to ageing and resistance exercise in humans. Exp Physiol. 2006;91(3):483–498.
   PubMed Web of Science ®Google Scholar
• Reid KF, Fielding RA. Skeletal muscle power: a critical determinant of physical functioning in older adults. Exerc Sport Sci Rev. 2012;40(1):4–12.
   PubMed Web of Science ®Google Scholar
• Vigen R, O’Donnell CI, Baron AE, et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. Jama. 2013;310(17):1829–1836.
   PubMed Web of Science ®Google Scholar
• Finkle WD, Greenland S, Ridgeway GK, et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One. 2014;9(1):e85805.
   PubMed Web of Science ®Google Scholar
• Xu L, Freeman G, Cowling BJ, et al. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials. BMC Med. 2013;11:108.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ. Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse. Med J Aust. 2013;199(8):548–551.
   PubMed Web of Science ®Google Scholar
• Gabrielsen JS, Najari BB, Alukal JP, et al. Trends in testosterone prescription and public health concerns. Urol Clin North Am. 2016;43(2):261–271.
   PubMed Web of Science ®Google Scholar
• Administration USFaD. FDA adding general warning to testosterone products about potential for venous blood clots. U.S. Food and Drug Administration, U.S. Department of Health & Human Services. 2014. Available from: http://wayback.archive-it.org/7993/20170112164224/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm402054.htm
   Google Scholar
• Administration USFaD. FDA drug safety communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. U.S. Food and Drug Administration, U.S. Department of Health & Human Services. 2015. Available from:https://wayback.archive-it.org/7993/20170112164024/http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm436280.htm
   Google Scholar
• Orwoll E, Lambert LC, Marshall LM, et al. Testosterone and estradiol among older men. J Clin Endocrinol Metab. 2006;91(4):1336–1344.
   PubMed Web of Science ®Google Scholar
• Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol. 1998;147(8):750–754.
   PubMed Web of Science ®Google Scholar
• Gray A, Feldman HA, McKinlay JB, et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991;73(5):1016–1025.
   PubMed Web of Science ®Google Scholar
• Muller M, Den Tonkelaar I, Thijssen JH, et al. Endogenous sex hormones in men aged 40–80 years. Eur J Endocrinol. 2003;149(6):583–589.
   PubMed Web of Science ®Google Scholar
• Bjornerem A, Straume B, Midtby M, et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab. 2004;89(12):6039–6047.
   PubMed Web of Science ®Google Scholar
• Jasuja GK, Travison TG, Davda M, et al. Age trends in estradiol and estrone levels measured using liquid chromatography tandem mass spectrometry in community-dwelling men of the Framingham Heart Study. J Gerontol A Biol Sci Med Sci. 2013;68(6):733–740.
   PubMed Web of Science ®Google Scholar
• Akram ON, Bursill C, Desai R, et al. Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays. Anal Chem. 2011;83(6):2065–2074.
   PubMed Web of Science ®Google Scholar
• Deslypere JP, Young M, Wilson JD, et al. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol Cell Endocrinol. 1992;88(1–3):15–22.
   PubMed Web of Science ®Google Scholar
• Zhou ZX, Lane MV, Kemppainen JA, et al. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol. 1995;9(2):208–218.
   PubMed Web of Science ®Google Scholar
• Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell. 2005;122(5):751–762.
   PubMed Web of Science ®Google Scholar
• Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361(12):1152–1163.
   PubMed Web of Science ®Google Scholar
• Lakshman KM, Bhasin S, Araujo AB. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci. 2010;65(5):503–509.
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Naganathan V, et al. Associations between circulating reproductive hormones and SHBG and prevalent and incident metabolic syndrome in community-dwelling older men: the Concord Health and Ageing in Men Project. J Clin Endocrinol Metab. 2014;99(12):E2686–2691.
   PubMed Web of Science ®Google Scholar